Adams To File Citizen Petition In Move To Block Generic Mucinex
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics is planning to file a citizen petition in an attempt to fend off generic competition against its 600 mg and 1200 mg Mucinex product (extended-release guaifenesin)
You may also be interested in...
Adams’ Suit Could Delay ANDA For URL/Mutual’s Mucinex Generic
A lawsuit filed by Adams Respiratory Therapeutics could bring a stay of up to 30 months on FDA's approval of Mutual Pharmaceuticals and United Research Laboratories' application for a generic version of Adams' Mucinex extended-release expectorant product
Adams’ Suit Could Delay ANDA For URL/Mutual’s Mucinex Generic
A lawsuit filed by Adams Respiratory Therapeutics could bring a stay of up to 30 months on FDA's approval of Mutual Pharmaceuticals and United Research Laboratories' application for a generic version of Adams' Mucinex extended-release expectorant product
Adams’ Suit Could Delay ANDA For URL/Mutual’s Mucinex Generic
A lawsuit filed by Adams Respiratory Therapeutics could bring a stay of up to 30 months on FDA's approval of Mutual Pharmaceuticals and United Research Laboratories' application for a generic version of Adams' Mucinex extended-release expectorant product
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: